HPV vaccine moves into late stage trials.
作者信息
Connett H
出版信息
Nat Med. 2001 Apr;7(4):388. doi: 10.1038/86408.
DOI:10.1038/86408
PMID:11283639
Abstract
摘要
相似文献
1
HPV vaccine moves into late stage trials.
Nat Med. 2001 Apr;7(4):388. doi: 10.1038/86408.
2
[Prophylactic and therapeutic vaccine therapy in papillomavirus infections].
Gynecol Obstet Fertil. 2000 May;28(5):370-84.
3
[HPV vaccination--a possibility for prevention of cervical cancer].
Duodecim. 2002;118(21):2159-60.
4
A human papillomavirus type 16 vaccine.
N Engl J Med. 2003 Apr 3;348(14):1402-5; author reply 1402-5.
5
A human papillomavirus type 16 vaccine.
N Engl J Med. 2003 Apr 3;348(14):1402-5; author reply 1402-5. doi: 10.1056/NEJM200304033481418.
6
Current clinical trials of HPV vaccines.
Oncology (Williston Park). 2004 Jun;18(7):859-60, 862.
7
Human papillomavirus vaccines.
Curr Opin Mol Ther. 2002 Feb;4(1):15-22.
8
[Biology of the papillomavirus infections: V. Vaccine developments].
Ann Biol Clin (Paris). 1999 Sep-Oct;57(5):517-24.
9
HPV vaccines--why aren't they the answer yet?
Med Health R I. 2005 Mar;88(3):74-9.
10
[Human papillomavirus: a vaccine against cervical carcinoma uterine].
Epidemiol Prev. 2002 May-Jun;26(3):140-4.
引用本文的文献
1
Gene Therapy Applications to Cancer Treatment.
J Biomed Biotechnol. 2003;2003(1):35-47. doi: 10.1155/S1110724303209037.
2
Cost-effectiveness of a potential vaccine for human papillomavirus.
Emerg Infect Dis. 2003 Jan;9(1):37-48. doi: 10.3201/eid0901.020168.
3
Time course of humoral and cell-mediated immune responses to human papillomavirus type 16 in infected women.
Clin Diagn Lab Immunol. 2002 Jul;9(4):877-82. doi: 10.1128/cdli.9.4.877-882.2002.
4
Antigen-driven T-cell selection in patients with cervical cancer as evidenced by T-cell receptor analysis and recognition of autologous tumor.
Clin Diagn Lab Immunol. 2002 Mar;9(2):267-78. doi: 10.1128/cdli.9.2.267-278.2002.
Zotero 插件